QPCT and Alzheimer disease: However, despite the debate about the most toxic form of Aβ, it is important to note that a number of current strategies e.g. glutaminyl cyclase inhibition and immunotherapy, involved in the treatment and/or prevention of AD progression are indeed directed against the deposition of plaques [6], [57].